Case-control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables. Eur J Cancer Prev

Department of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland.
European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) (Impact Factor: 3.03). 11/2009; 19(1):42-7. DOI: 10.1097/CEJ.0b013e328333d0cc
Source: PubMed


Laboratory in-vitro studies and animal experiments showing the potential health benefits from apples raises the question to what extent the regular consumption of apples in humans may have a beneficial effect on colorectal cancer risk. A total of 592 incident cases of colorectal cancer have been enrolled in a hospital-based case-control study. The comparison group included 765 controls chosen from the patients of the same hospital without history of cancer and admitted for treatment of nonneoplastic conditions. Interviews of both cases and controls were conducted in the hospital setting by trained interviewers. The median intake of fruits among cases was lower than in controls (9.5 vs. 11 servings/week) and the difference was statistically significant. Apples were the most frequent fruit consumed by the study participants and about 80% of variability in the total fruit consumption resulted from the intake of apples. We did not observe any significant statistical differences in consumption of berries, citrus, or stone fruits and other kinds of fruits across cases and controls. The adjusted estimates of colorectal cancer risk related to the daily consumption of apples (in quintiles) were based on the unconditional multivariate logistic model, which considered the set of potential confounding variables such as demographic characteristics of participants (age, gender, place of residency, marital status, tobacco smoking), total energy intake, intake of vegetables and fruits without apples. The results of the logistic analysis showed that the adjusted risk of colorectal cancer inversely correlated with daily number of apple servings. The reduced risk of colorectal cancer of border significance level was already observed at the consumption of at least one apple a day (odds ratio=0.65, 95% CI: 0.39-1.09), but at the intake of more than one apple a day the risk was reduced by about 50% (odds ratio=0.53, 95% CI: 0.35-0.79). Neither the consumption of vegetables nor other fruits have shown beneficial effects on the risk of colorectal cancer. The observed protective effect of apple consumption on colorectal risk may result from their rich content of flavonoid and other polyphenols, which can inhibit cancer onset and cell proliferation.

Download full-text


Available from: Agnieszka Pac
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: A favorable effect over development of degenerative diseases is derived of an adecuate intake of fruit and vegetables, mainly due to their antioxidant compounds Objectives: The goal of this study was to test the effect in vivo over oxidant status and inflammation in obese children of a novel food product made of dried apples enriched with mandarin juice by vacuum impregnation. Methods: A four-week intervention study was conducted in 41 obese children (> 2 standard deviation score-body mass index). Participants were instructed to follow their usual diet supplemented with 40 g/day of the developed product. Anthropometric parameters were determined including body mass index, waist circumference and estimations of body fat percentage using bioelectrical impedance. Dietary intake was assessed by questionnaire. Metabolic risk factors (blood pressure, lipid profile, glucose and insulin resistance) were recorded. To determine oxidant status, plasma total antioxidant capacity and 8- hydroxydeoxyguanosine, as marker of oxidative damage to DNA, were investigated. High-sensitive C-reactive protein, tumor necrosis factor-?, and interleukins 6 and 1-??were measured as inflammatory markers. Measurements were collected at baseline and at the end of the intervention period. Results: Significant improvement in systolic blood pressure and lipid profile after intervention period was noted. A significant increase in the antioxidant capacity of plasma (ABTS and FRAP assays) and reductions in DNA oxidative damage and inflammatory markers were also found. Conclusion: Overall, adding the product to the diet contributes to ameliorate oxidant and inflammatory status in obese children and several risk factors for athe - rosclerosis.
    No preview · Article · Jul 2013 · Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral
  • [Show abstract] [Hide abstract]
    ABSTRACT: The systemic therapy for colorectal cancer has advanced from essentially a single, partially effective agent, 5-fluorouracil, to a combination of cytotoxics and antibodies offering increased survival. In addition to damage of DNA through agents, such as oxaliplatin and irinotecan, and inhibition of DNA replication, a promising approach involves modifying the control of gene expression, including epigenetic control. Modulation of invasion and metastasis should become increasingly important. Inhibition of growth-factor signaling with small-molecule drugs and antibodies can be a part of this effort. Further progress in the control of gene expression in colon cancer may be achieved with miRNAs and RNA interference if technical problems can be overcome. A number of genetic changes in colorectal cancer progression have been identified and offer targets for future therapy.
    No preview · Article · Jun 2010 · Future Oncology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Polyphenols, occurring in vegetables, fruits, herbs, spices, propolis, tea, beer, and wine play an important role in cancer chemoprevention. Dietary polyphenols exert their chemopreventive effect by multiple molecular mechanisms of action on apoptosis signaling pathways in cancer cells. In this review, we describe dietary polyphenols targeting the tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptotic pathway. TRAIL is a natural potent anticancer agent that preferentially induces apoptosis in cancer cells and is not toxic to normal cells. Soluble or expressed on immune cells, molecules of TRAIL take part in immune surveillance and defense mechanisms against tumor cells. However, some cancer cells are resistant to TRAIL-mediated cytotoxicity. The decreased expression of death receptors (TRAIL-R1, TRAIL-R2) and proapoptotic proteins or increased expression of antiapoptotic proteins in cancer cells is involved in TRAIL resistance. There is a growing body of experimental evidence showing that polyphenols sensitize TRAIL-resistant cancer cells and markedly augment TRAIL-induced programmed death in cancer cells. These in-vitro and in-vivo studies indicate the significance of dietary polyphenols in cancer chemoprevention strategies through enhancing the apoptosis-inducing potential of TRAIL.
    No preview · Article · Jan 2011 · European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP)
Show more